Like Digital Artefacts LLC

closed 11/10/2021 via BusinessWire

Clinical Ink, acquired Digital Artefacts LLC

synopsis: Clinical Ink, a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct, has acquired Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.
buyer parent: GI Partners
buyer: Clinical Ink
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Clinical Ink's Lunexis technology provides a suite of solutions for capturing and integrating electronic data from sites, clinicians, caregivers, and patients at its source. "
target: Digital Artefacts LLC
Digital Artefacts (DA) provides study design services and an end-to-end digital health platform to run decentralized clinical studies. DA is the creator of the BrainBaseline platform, an extensive, modularized digital toolbox for clinical assessment and measurement in or outside of a clinic.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2017 via PR Newswire

Bracket Global, acquired mProve Health

synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of mProve Health Inc., a leading provider of mobile technologies for life science companies. mProve Health offers regulatory compliant mobile solutions for patient recruitment and electronic clinical outcome assessments.
buyer parent: Genstar Capital LLC
buyer: Bracket Global
Bracket is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. "
target: mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/8/2008 via BusinessWire

PeerView, Inc., purchased Veritas Clinical Trials Register™ platform from Veritas Medicine, Inc.

synopsis: PeerView today announced that it has completed the acquisition of the Veritas Clinical Trials Register™ platform from Veritas Medicine, a privately held company headquartered in Cambridge, Mass.
buyer: PeerView, Inc.
PeerView is a leading provider of medical publishing solutions that enable medical affairs departments and their medical communications partners to design and support efficient and transparent publication planning processes. "
seller: Veritas Medicine, Inc.
VeritasMedicine.com is an online health resource focused on improving patient access to clinical trials and information about therapies in development for serious medical conditions. The centerpiece of VeritasMedicine.com is a comprehensive clinical trials database.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2005 via PR Newswire

DataLabs, acquired Broadpeak LLC

synopsis: DataLabs announced that it has acquired Broadpeak LLC, an eClinical Collaboration software company that provides applications to the biopharmaceutical and Contract Research Organizations (CRO) industries to improve the workflow and communication processes in managing clinical trials.
buyer: DataLabs
DataLabs is an innovative developer of Internet-based applications for clinical development that helps the biopharmaceutical industry accelerate clinical trials with proven software for study design, data capture and data management. "
target: Broadpeak LLC
Broadpeak's application suite is an eClinical Collaboration System that paves the way for the next generation in Clinical Trial Management Systems (CTMS). The Broadpeak solution facilitates all internal and external collaboration for study activities, from beginning to end.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2021 via BusinessWire

Clinical Ink, acquired Digital Artefacts LLC

synopsis: Clinical Ink, a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct, has acquired Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.
buyer parent: GI Partners
buyer: Clinical Ink
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Clinical Ink's Lunexis technology provides a suite of solutions for capturing and integrating electronic data from sites, clinicians, caregivers, and patients at its source. "
target: Digital Artefacts LLC
Digital Artefacts (DA) provides study design services and an end-to-end digital health platform to run decentralized clinical studies. DA is the creator of the BrainBaseline platform, an extensive, modularized digital toolbox for clinical assessment and measurement in or outside of a clinic.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2021 via BusinessWire

Clinical Ink, acquired Digital Artefacts LLC

synopsis: Clinical Ink, a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct, has acquired Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.
buyer parent: GI Partners
buyer: Clinical Ink
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Clinical Ink's Lunexis technology provides a suite of solutions for capturing and integrating electronic data from sites, clinicians, caregivers, and patients at its source. "
target: Digital Artefacts LLC
Digital Artefacts (DA) provides study design services and an end-to-end digital health platform to run decentralized clinical studies. DA is the creator of the BrainBaseline platform, an extensive, modularized digital toolbox for clinical assessment and measurement in or outside of a clinic.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2020 via BusinessWire

GI Partners, acquired Clinical Ink

synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer: GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent: NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/15/2018 via Company Press Release

NovaQuest, acquired Clinical Ink

synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer: NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/18/2015 via BusinessWire

CentrosHealth merged with Clinical Ink,

synopsis: Clinical Ink, the pioneering provider of eSource solutions for clinical trials, announced a merger with CentrosHealth, the ground-breaking provider of configurable mobile apps for clinical trial patient engagement and electronic patient reported outcomes.
buyer: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol. "
target: CentrosHealth
CentrosHealth is a mobile app platform designed to improve the patient experience during a clinical trial, including: patient engagement, compliance, retention, and data capture.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2021 via BusinessWire

Clinical Ink, acquired Digital Artefacts LLC

synopsis: Clinical Ink, a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct, has acquired Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.
buyer parent: GI Partners
buyer: Clinical Ink
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Clinical Ink's Lunexis technology provides a suite of solutions for capturing and integrating electronic data from sites, clinicians, caregivers, and patients at its source. "
target: Digital Artefacts LLC
Digital Artefacts (DA) provides study design services and an end-to-end digital health platform to run decentralized clinical studies. DA is the creator of the BrainBaseline platform, an extensive, modularized digital toolbox for clinical assessment and measurement in or outside of a clinic.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2020 via BusinessWire

GI Partners, acquired Clinical Ink

synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer: GI Partners
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent: NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/15/2018 via Company Press Release

NovaQuest, acquired Clinical Ink

synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer: NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target: Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/17/2017 via BNC Analysis

Roche Ltd, will acquire Viewics, Inc.

synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

ERT, acquired invivodata, Inc.

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes (ePRO) solutions and Consulting services, based in Pittsburgh, PA.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. "
target: invivodata, Inc.
invivodata is a fully-integrated Clinical Outcome Assessments organization delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/18/2021 via BusinessWire

Verily Life Sciences, will acquire SignalPath

synopsis: Verily, an Alphabet company focused on life sciences and healthcare, will acquire SignalPath, a clinical trial management system (CTMS) that improves the ease and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
buyer parent: Google
buyer: Verily Life Sciences
Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. The company develops tools to collect and activate health data, and creates interventions to prevent and manage disease. "
target: SignalPath
SignalPath is a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2021 via BusinessWire

Francisco Partners Management LLC, will acquire STARLIMS

synopsis: Francisco Partners is to acquire the STARLIMS informatics product suite and related business assets from Abbott. A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Francisco Partners has raised approximately $25 billion in committed capital and invested in more than 300 technology companies. "
target parent: Abbott Laboratories
target: STARLIMS (LIMS:$25.24)
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/6/2019 via BNC Analysis

Advarra, will acquire Forte Research Systems

synopsis: Advarra, the premier provider of institutional review board, institutional biosafety committee, and research quality and compliance consulting services, will acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Primus
target: Forte Research Systems
Forte provides software and services in the critical areas of clinical trial management, clinical data management, and research administration for cancer centers, academic medical centers, and health systems. Forte's flagship Clinical Trial Management System, OnCore manages clinical research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 1/27/2015 via PR Newswire

genae, acquired e-novex

synopsis: genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced the acquisition of e-novex, a leading provider of electronic data tools that change medical research. e-novex' proprietory Electronic Data Capture (EDC) technology is widely adopted by various types of medical research organizations.
buyer: genae
genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice. As a full service CRO and innovative services provider for the medical industries, genae aims at improving health and quality of life. "
target: e-novex
e-novex is a certified web technology company that provides electronic data tools that facilitates medical research. e-capture.net is an intuitive and user-centric EDC platform that features easy data entry, complex validation rules and flexible reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/19/2021 via BNC Analysis

Glintt, acquired FarmaTools

synopsis: Glintt, a leading consulting and technological services company based in Portugal, has acquired FarmaTools from Dominion Global, a global provider of multitechnology services. FarmaTools is a hospital pharmacy software solutions provider in Spain. Their software provides solutions for administrative management and clinical management.
buyer: Glintt (ENXTLS:GLINT:$108.88)
Glintt is a leading consulting and technological services company based in Portugal. Glintt develops products for hospitals, clinics and pharmacies. They support their clients in their digital transformation and offers software solutions that helps them to run their business more efficiently. "
target parent: Dominion Global
target: FarmaTools
FarmaTools is a pharmacy software solutions provider in Spain. FarmaTools offers an innovative, effective, and automated system for hospital pharmacies. Their software provides solutions for administrative management and clinical management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/5/2020 via Company Press Release

Clanwilliam Group Ltd., acquired KM Medical Software

synopsis: Clanwilliam Group, a global family of businesses committed to healthcare, technology and services, has acquired KM Medical Software, an Irish company that specialises in cloud-based EMR solutions. KM Medical's iMedDoc solution allows users to access their patient records at anytime and anywhere using a desktop or mobile device.
buyer parent: Global Growth
buyer: Clanwilliam Group Ltd.
Clanwilliam Group, headquartered in Dublin, is an expanding healthcare, technology and services business. They develop, sell and integrate a range of technology solutions and services predominately to the GP, Private Consultant and pharmacy communities. "
target: KM Medical Software
KM Medical Software is an Irish company that specialises in cloud-based EMR solutions for surgeons, physiotherapists and other specialists. KM Medical's iMedDoc solution allows users to access their patient records at anytime and anywhere using a desktop or mobile device.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via BusinessWire

Elligo Health Research, acquired Root Health, Inc.

synopsis: Elligo Health Research, a healthcare-enabling research organization, has acquired Root Health, an AI virtual assistant for clinical research. Root Health helps researchers to compile, track, and support study operations through a dashboard. It automates participant communication, triage, and reporting so users can focus on clinical interactions.
buyer: Elligo Health Research
Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. "
target: Root Health, Inc.
Root Health is an AI virtual assistant for clinical research. Root Health helps researchers to compile, track, and support study operations through a dashboard. It automates participant communication, triage, data collection, and reporting so users can focus on one-on-one clinical interactions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/11/2018 via Company Press Release

Genpact Ltd, will acquire Commonwealth Informatics Inc.

synopsis: Genpact, a professional services firm focused on delivering digital transformation, announced that it has signed a definitive agreement to acquire Commonwealth Informatics, Inc. (CI), a market-leading provider of cloud-based drug safety analytics products and services for medical research and healthcare delivery headquartered near Boston, Mass.
buyer: Genpact Ltd (G:$3,699.55)
Genpact is a global professional services firm that makes business transformation real. They drive digital-led innovation and digitally-enabled intelligent operations for their clients. They think with design, dream in digital, and solve problems with data and analytics. "
target: Commonwealth Informatics Inc.
Commonwealth Informatics provides cloud-based drug safety analytics products and services for medical research and healthcare delivery. Their Commonwealth Vigilance Workbench consists of integrated modules used by pharmaceutical and biotech companies, government agencies, and healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2021 via BusinessWire

Alira Health S.A.S., acquired BePatient

synopsis: Alira Health, a leading technology-enabled services provider, has acquired BEPATIENT, a French healthcare technology company. BEPATIENT offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical technology companies, associations, and public institutions.
buyer: Alira Health S.A.S.
Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. The company provides a suite of integrated services designed to help healthcare and life science companies innovate and grow across their solutions lifecycle. "
target: BePatient
BEPATIENT is a French company that has a comprehensive and modular core platform, enabling patients to be connected at home to healthcare professionals and to generate value-added Real-World Evidence (RWE) data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2021 via PR Newswire

Pemba Capital Partners, will acquire RxMx

synopsis: Pemba Capital Partners announced it has entered an international growth partnership agreement with and acquired a majority stake in global healthtech company RxMx, a provider of specialty medicine management systems. RxMx has developed an ecosystem of apps and portals to connect patients, doctors, nurses, caregivers and manufacturers.
buyer: Pemba Capital Partners
Pemba Capital Partners was established in 1998 and is a leading investor in small and mid-sized private businesses in Australia and New Zealand. Since inception the investment firm has specialised in partnering with the owners and managers of private businesses to help them accelerate growth. "
target: RxMx
Based in Sydney, Australia, RxMx built its business on the idea that by automating certain tasks, it could empower doctors and nurses to safely administer specialty medicines without increasing their burden, improving patient safety and patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/27/2020 via BNC Analysis

Caravan Health, acquired Wellpepper

synopsis: Caravan Health, a leader in accountable care and population health programs for community health systems, has acquired Wellpepper, a clinically-validated patient engagement platform. Wellpepper enables healthcare systems to deliver highly actionable and engaging mobile treatment plans that increase patient adherence and improve outcomes.
buyer: Caravan Health
Caravan Health is a leader in accountable care and population health programs for community health systems. Caravan Health builds and manages accountable care organizations (ACOs) to support physicians and community hospitals in their goals of improving patient care and clinician satisfaction. "
target: Wellpepper
Wellpepper is an award-winning and clinically-validated patient engagement platform. Wellpepper enables healthcare systems to deliver highly actionable and engaging mobile treatment plans that increase patient adherence and improve outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Digital Artefacts LLC


read more

Digital Artefacts LLC

mProve Health

Veritas Medicine, Inc.

Broadpeak LLC

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

ClinIntel Ltd.

read more

Digital Artefacts LLC

read more

Digital Artefacts LLC

Clinical Ink

Clinical Ink

CentrosHealth

read more

Digital Artefacts LLC

Clinical Ink

Clinical Ink

HealthMode

Viewics, Inc.

invivodata, Inc.

Bio-Optronics Group, LLC

SignalPath

STARLIMS

Habitu Health

Forte Research Systems

OmniComm Systems, Inc.

e-novex

FarmaTools

KM Medical Software

Root Health, Inc.

Commonwealth Informatics Inc.

BePatient

RxMx

Wellpepper

Geography
Matching Companies
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:PKS
 
 
 
 
 
 
 
 
Pacific Knowledge Systems
Pacific Knowledge Systems
Pacific Knowledge Systems (PKS) is an Australian provider of clinical expert intelligence. Their RippleDown solution integrates patient data with a knowledge base that is managed by clinical domain experts, to deliver patient-specific reports, recommendation and alerts.
year
2021
rev ($mm)
$6.12
EBITDA ($mm)
($0.30)
EBIT ($mm)
($0.35)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch